{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:56:47Z","timestamp":1793494607054,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T00:00:00Z","timestamp":1682294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T00:00:00Z","timestamp":1682294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea","award":["HA21C0065"],"award-info":[{"award-number":["HA21C0065"]}]},{"DOI":"10.13039\/501100008005","name":"Yonsei University College of Medicine","doi-asserted-by":"publisher","award":["6-2021-0142"],"award-info":[{"award-number":["6-2021-0142"]}],"id":[{"id":"10.13039\/501100008005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The management and follow-up of moderate aortic stenosis (AS) lacks consensus as the progression patterns are not well understood. This study aimed to identify the hemodynamic progression of AS, and associated risk factors and outcomes. We included patients with moderate AS with at least three transthoracic echocardiography (TTE) studies performed between 2010 and 2021. Latent class trajectory modeling was used to classify AS groups with distinctive hemodynamic trajectories, which were determined by serial systolic mean pressure gradient (MPG) measurements. Outcomes were defined as all-cause mortality and aortic valve replacement (AVR). A total of 686 patients with 3093 TTE studies were included in the analysis. Latent class model identified two distinct AS trajectory groups based on their MPG: a slow progression group (44.6%) and a rapid progression group (55.4%). Initial MPG was significantly higher in the rapid progression group (28.2\u2009\u00b1\u20095.6\u00a0mmHg vs. 22.9\u2009\u00b1\u20092.8\u00a0mmHg, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The prevalence of atrial fibrillation was higher in the slow progression group; there was no significant between-group difference in the prevalence of other comorbidities. The rapid progression group had a significantly higher AVR rate (HR 3.4 [2.4\u20134.8], <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001); there was no between-group difference in mortality (HR 0.7 [0.5\u20131.0]; <jats:italic>P<\/jats:italic>\u2009=\u20090.079). Leveraging longitudinal echocardiographic data, we identified two distinct groups of patients with moderate AS: slow and rapid progression. A higher initial MPG (\u2265\u200924\u00a0mmHg) was associated with more rapid progression of AS and higher rates of AVR, thus indicating the predictive value of MPG in management of the disease.<\/jats:p>","DOI":"10.1038\/s41598-023-33683-1","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T17:03:03Z","timestamp":1682355783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Reclassification of moderate aortic stenosis based on data-driven phenotyping of hemodynamic progression"],"prefix":"10.1038","volume":"13","author":[{"given":"Iksung","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu-Yong","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeonchan","family":"Seong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwon","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Young","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Won","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aakriti","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seng Chan","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geu-Ru","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harlan M.","family":"Krumholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,24]]},"reference":[{"key":"33683_CR1","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1161\/CIR.0000000000000923","volume":"143","author":"CM Otto","year":"2021","unstructured":"Otto, C. M. et al. 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 143, e72\u2013e227. https:\/\/doi.org\/10.1161\/CIR.0000000000000923 (2021).","journal-title":"Circulation"},{"key":"33683_CR2","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1093\/eurheartj\/ehp575","volume":"31","author":"A Vahanian","year":"2010","unstructured":"Vahanian, A. & Otto, C. M. Risk stratification of patients with aortic stenosis. Eur. Heart J. 31, 416\u2013423. https:\/\/doi.org\/10.1093\/eurheartj\/ehp575 (2010).","journal-title":"Eur. Heart J."},{"key":"33683_CR3","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1056\/NEJM200008313430903","volume":"343","author":"R Rosenhek","year":"2000","unstructured":"Rosenhek, R. et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N. Engl. J. Med. 343, 611\u2013617. https:\/\/doi.org\/10.1056\/NEJM200008313430903 (2000).","journal-title":"N. Engl. J. Med."},{"key":"33683_CR4","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jacc.2019.04.065","volume":"74","author":"L Tastet","year":"2019","unstructured":"Tastet, L. et al. Staging cardiac damage in patients with asymptomatic aortic valve stenosis. J. Am. Coll. Cardiol. 74, 550\u2013563. https:\/\/doi.org\/10.1016\/j.jacc.2019.04.065 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"33683_CR5","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1093\/eurheartj\/ehx381","volume":"38","author":"P Genereux","year":"2017","unstructured":"Genereux, P. et al. Staging classification of aortic stenosis based on the extent of cardiac damage. Eur. Heart J. 38, 3351\u20133358. https:\/\/doi.org\/10.1093\/eurheartj\/ehx381 (2017).","journal-title":"Eur. Heart J."},{"key":"33683_CR6","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/j.jacc.2019.08.004","volume":"74","author":"G Strange","year":"2019","unstructured":"Strange, G. et al. Poor long-term survival in patients with moderate aortic stenosis. J. Am. Coll. Cardiol. 74, 1851\u20131863. https:\/\/doi.org\/10.1016\/j.jacc.2019.08.004 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"33683_CR7","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1001\/jamacardio.2021.3718","volume":"6","author":"A Coisne","year":"2021","unstructured":"Coisne, A. et al. Association of mortality with aortic stenosis severity in outpatients: Results from the VALVENOR study. JAMA Cardiol. 6, 1424\u20131431. https:\/\/doi.org\/10.1001\/jamacardio.2021.3718 (2021).","journal-title":"JAMA Cardiol."},{"key":"33683_CR8","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1001\/jama.2020.2278","volume":"324","author":"M Mori","year":"2020","unstructured":"Mori, M., Krumholz, H. M. & Allore, H. G. Using latent class analysis to identify hidden clinical phenotypes. JAMA 324, 700\u2013701. https:\/\/doi.org\/10.1001\/jama.2020.2278 (2020).","journal-title":"JAMA"},{"key":"33683_CR9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.4758","volume":"2","author":"S Wu","year":"2019","unstructured":"Wu, S. et al. Association of trajectory of cardiovascular health score and incident cardiovascular disease. JAMA Netw. Open 2, e194758. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.4758 (2019).","journal-title":"JAMA Netw. Open"},{"key":"33683_CR10","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm, E. et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. BMJ 335, 806\u2013808. https:\/\/doi.org\/10.1136\/bmj.39335.541782.AD (2007).","journal-title":"BMJ"},{"key":"33683_CR11","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S0894-7317(03)00685-0","volume":"16","author":"MD Cheitlin","year":"2003","unstructured":"Cheitlin, M. D. et al. ACC\/AHA\/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary article. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (ACC\/AHA\/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J. Am. Soc. Echocardiogr. 16, 1091\u20131110. https:\/\/doi.org\/10.1016\/S0894-7317(03)00685-0 (2003).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"33683_CR12","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1161\/01.cir.71.6.1162","volume":"71","author":"PJ Currie","year":"1985","unstructured":"Currie, P. J. et al. Continuous-wave Doppler echocardiographic assessment of severity of calcific aortic stenosis: A simultaneous Doppler-catheter correlative study in 100 adult patients. Circulation 71, 1162\u20131169. https:\/\/doi.org\/10.1161\/01.cir.71.6.1162 (1985).","journal-title":"Circulation"},{"key":"33683_CR13","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1161\/01.cir.72.4.810","volume":"72","author":"T Skjaerpe","year":"1985","unstructured":"Skjaerpe, T., Hegrenaes, L. & Hatle, L. Noninvasive estimation of valve area in patients with aortic stenosis by Doppler ultrasound and two-dimensional echocardiography. Circulation 72, 810\u2013818. https:\/\/doi.org\/10.1161\/01.cir.72.4.810 (1985).","journal-title":"Circulation"},{"key":"33683_CR14","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1016\/j.jacc.2014.02.537","volume":"63","author":"RA Nishimura","year":"2014","unstructured":"Nishimura, R. A. et al. 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 63, 2438\u20132488. https:\/\/doi.org\/10.1016\/j.jacc.2014.02.537 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"33683_CR15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1001\/jamacardio.2019.4867","volume":"5","author":"RB Patel","year":"2020","unstructured":"Patel, R. B. et al. Association of longitudinal trajectory of albuminuria in young adulthood with myocardial structure and function in later life: Coronary artery risk development in young adults (CARDIA) study. JAMA Cardiol. 5, 184\u2013192. https:\/\/doi.org\/10.1001\/jamacardio.2019.4867 (2020).","journal-title":"JAMA Cardiol."},{"key":"33683_CR16","doi-asserted-by":"publisher","DOI":"10.4159\/9780674041318","volume-title":"Group-Based Modeling of Development","author":"DS Nagin","year":"2005","unstructured":"Nagin, D. S. Group-Based Modeling of Development (Harvard University Press, 2005)."},{"key":"33683_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","volume":"6","author":"DS Nagin","year":"2010","unstructured":"Nagin, D. S. & Odgers, C. L. Group-based trajectory modeling in clinical research. Annu. Rev. Clin. Psychol. 6, 109\u2013138. https:\/\/doi.org\/10.1146\/annurev.clinpsy.121208.131413 (2010).","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"33683_CR18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.cpcardiol.2013.06.003","volume":"38","author":"C Gohlke-Barwolf","year":"2013","unstructured":"Gohlke-Barwolf, C. et al. Natural history of mild and of moderate aortic stenosis-new insights from a large prospective European study. Curr. Probl. Cardiol. 38, 365\u2013409. https:\/\/doi.org\/10.1016\/j.cpcardiol.2013.06.003 (2013).","journal-title":"Curr. Probl. Cardiol."},{"key":"33683_CR19","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1136\/hrt.2004.036848","volume":"91","author":"J Kuusisto","year":"2005","unstructured":"Kuusisto, J., Rasanen, K., Sarkioja, T., Alarakkola, E. & Kosma, V. M. Atherosclerosis-like lesions of the aortic valve are common in adults of all ages: A necropsy study. Heart 91, 576\u2013582. https:\/\/doi.org\/10.1136\/hrt.2004.036848 (2005).","journal-title":"Heart"},{"key":"33683_CR20","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.jacc.2016.02.057","volume":"67","author":"P Genereux","year":"2016","unstructured":"Genereux, P. et al. Natural history, diagnostic approaches, and therapeutic strategies for patients with asymptomatic severe aortic stenosis. J. Am. Coll. Cardiol. 67, 2263\u20132288. https:\/\/doi.org\/10.1016\/j.jacc.2016.02.057 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"33683_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1055\/s-0031-1278283","volume":"17","author":"AR Kamath","year":"2008","unstructured":"Kamath, A. R. & Pai, R. G. Risk factors for progression of calcific aortic stenosis and potential therapeutic targets. Int. J. Angiol. 17, 63\u201370. https:\/\/doi.org\/10.1055\/s-0031-1278283 (2008).","journal-title":"Int. J. Angiol."},{"key":"33683_CR22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.amjcard.2014.09.049","volume":"115","author":"M Ersboll","year":"2015","unstructured":"Ersboll, M. et al. Predictors and progression of aortic stenosis in patients with preserved left ventricular ejection fraction. Am. J. Cardiol. 115, 86\u201392. https:\/\/doi.org\/10.1016\/j.amjcard.2014.09.049 (2015).","journal-title":"Am. J. Cardiol."},{"key":"33683_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2022.10.009","author":"N Willner","year":"2022","unstructured":"Willner, N. et al. Aortic stenosis progression: A systematic review and meta-analysis. JACC Cardiovasc. Imaging https:\/\/doi.org\/10.1016\/j.jcmg.2022.10.009 (2022).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"33683_CR24","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1136\/heartjnl-2014-307154","volume":"101","author":"V Nguyen","year":"2015","unstructured":"Nguyen, V. et al. Haemodynamic and anatomic progression of aortic stenosis. Heart 101, 943\u2013947. https:\/\/doi.org\/10.1136\/heartjnl-2014-307154 (2015).","journal-title":"Heart"},{"key":"33683_CR25","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1093\/eurheartj\/ehx653","volume":"39","author":"F Peeters","year":"2018","unstructured":"Peeters, F. et al. Calcific aortic valve stenosis: Hard disease in the heart: A biomolecular approach towards diagnosis and treatment. Eur. Heart J. 39, 2618\u20132624. https:\/\/doi.org\/10.1093\/eurheartj\/ehx653 (2018).","journal-title":"Eur. Heart J."},{"key":"33683_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084433","volume":"8","author":"L Sun","year":"2013","unstructured":"Sun, L., Rajamannan, N. M. & Sucosky, P. Defining the role of fluid shear stress in the expression of early signaling markers for calcific aortic valve disease. PLoS\u00a0One 8, e84433. https:\/\/doi.org\/10.1371\/journal.pone.0084433 (2013).","journal-title":"PLoS\u00a0One"},{"key":"33683_CR27","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.121.008478","volume":"14","author":"AS Rivera","year":"2021","unstructured":"Rivera, A. S. et al. Long-term trajectories of left ventricular ejection fraction in patients with chronic inflammatory diseases and heart failure: An analysis of electronic health records. Circ. Heart Fail. 14, e008478. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.121.008478 (2021).","journal-title":"Circ. Heart Fail."},{"key":"33683_CR28","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1161\/CIRCULATIONAHA.119.044924","volume":"141","author":"A Loupy","year":"2020","unstructured":"Loupy, A. et al. Identification and characterization of trajectories of cardiac allograft vasculopathy after heart transplantation: A population-based study. Circulation 141, 1954\u20131967. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.044924 (2020).","journal-title":"Circulation"},{"key":"33683_CR29","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/eurheartj\/ehp530","volume":"31","author":"K Sliwa","year":"2010","unstructured":"Sliwa, K. et al. Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: Insights from the heart of Soweto study. Eur. Heart J. 31, 719\u2013727. https:\/\/doi.org\/10.1093\/eurheartj\/ehp530 (2010).","journal-title":"Eur. Heart J."},{"key":"33683_CR30","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.pcad.2014.02.006","volume":"56","author":"JJ Thaden","year":"2014","unstructured":"Thaden, J. J., Nkomo, V. T. & Enriquez-Sarano, M. The global burden of aortic stenosis. Prog. Cardiovasc. Dis. 56, 565\u2013571. https:\/\/doi.org\/10.1016\/j.pcad.2014.02.006 (2014).","journal-title":"Prog. Cardiovasc. Dis."},{"key":"33683_CR31","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/s0735-1097(99)00250-8","volume":"34","author":"MS Lauer","year":"1999","unstructured":"Lauer, M. S., Blackstone, E. H., Young, J. B. & Topol, E. J. Cause of death in clinical research: Time for a reassessment?. J. Am. Coll. Cardiol. 34, 618\u2013620. https:\/\/doi.org\/10.1016\/s0735-1097(99)00250-8 (1999).","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33683-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33683-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33683-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T17:07:27Z","timestamp":1682356047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33683-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,24]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["33683"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-33683-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,24]]},"assertion":[{"value":"11 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Gupta received consulting fees from Arnold and Porter Law Firm, Martin\/Baughman Law Firm, and Edwards LifeSciences. In the past three years, Dr. Krumholz received expenses and\/or personal fees from UnitedHealth, Element Science, Aetna, Reality Labs, Tesseract\/4Catalyst, F-Prime, the Siegfried and Jensen Law Firm, Arnold and Porter Law Firm, and Martin\/Baughman Law Firm. He is a co-founder of Refactor Health and HugoHealth, and is associated with contracts, through Yale New Haven Hospital, from the Centers for Medicare and Medicaid Services and through Yale University from Johnson and Johnson. Dr. You is a chief technology officer of PHI Digital Healthcare. Other authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6694"}}